Directs schools to provide information on meningococcal disease immunization to students and parents of students in seventh grade, and requires such schools to maintain record of responses as to whether such students have received such immunization.
Sponsor: HANNON / Co-sponsor(s): LARKIN / Committee: FINANCE
Law Section: Public Health Law / Law: Amd S2167, Pub Health L
Sponsor: HANNON / Co-sponsor(s): LARKIN / Committee: FINANCE
Law Section: Public Health Law / Law: Amd S2167, Pub Health L
S5069B-2011 Actions
- May 30, 2012: PRINT NUMBER 5069D
- May 30, 2012: AMEND AND RECOMMIT TO FINANCE
- May 22, 2012: PRINT NUMBER 5069C
- May 22, 2012: AMEND AND RECOMMIT TO FINANCE
- May 22, 2012: REPORTED AND COMMITTED TO FINANCE
- Jan 4, 2012: REFERRED TO HEALTH
- Jun 24, 2011: COMMITTED TO RULES
- Jun 14, 2011: ADVANCED TO THIRD READING
- Jun 13, 2011: 2ND REPORT CAL.
- Jun 7, 2011: 1ST REPORT CAL.1108
- Jun 2, 2011: PRINT NUMBER 5069B
- Jun 2, 2011: AMEND AND RECOMMIT TO FINANCE
- May 24, 2011: REPORTED AND COMMITTED TO FINANCE
- May 17, 2011: PRINT NUMBER 5069A
- May 17, 2011: AMEND AND RECOMMIT TO HEALTH
- May 3, 2011: REFERRED TO HEALTH
S5069B-2011 Meetings
Finance: Jun 7, 2011, Health: May 22, 2012S5069B-2011 Calendars
Floor Calendar: Jun 13, 2011 , Floor Calendar: Jun 14, 2011 , Floor Calendar: Jun 15, 2011 , Floor Calendar: Jun 16, 2011 , Floor Calendar: Jun 17, 2011 , Floor Calendar: Jun 21, 2011 , Floor Calendar: Jun 22, 2011 , Floor Calendar: Jun 23, 2011 , Floor Calendar: Jun 24, 2011S5069B-2011 Votes
VOTE: COMMITTEE VOTE:
- Health
- May 24, 2011
Ayes (16): Hannon, Ball, Farley, Fuschillo, Golden, Larkin, McDonald, Seward, Young, Duane, Gianaris, Kruger, Montgomery, Rivera, Smith, Stewart-Cousins
Ayes W/R (1): Adams
VOTE: COMMITTEE VOTE:
- Finance
- Jun 7, 2011
Ayes (32): DeFrancisco, Johnson, Alesi, Bonacic, Farley, Flanagan, Fuschillo, Golden, Griffo, Hannon, Lanza, Larkin, LaValle, Little, Marcellino, Nozzolio, Robach, Seward, Young, Krueger, Breslin, Diaz, Dilan, Duane, Gianaris, Montgomery, Oppenheimer, Parker, Perkins, Rivera, Stavisky, Stewart-Cousins
Ayes W/R (3): Saland, Kruger, Peralta
VOTE: COMMITTEE VOTE:
- Health
- May 22, 2012
Ayes (15): Hannon, Ball, Farley, Fuschillo, Golden, Larkin, Seward, Young, Duane, Adams, Gianaris, Montgomery, Rivera, Smith, Stewart-Cousins
Ayes W/R (1): Peralta
Excused (1): McDonald
S5069B-2011 Memo
BILL NUMBER:S5069 TITLE OF BILL: An act to amend the public health law, in relation to raising the level of immunity of children against meningococcal disease PURPOSE: To ensure that parents of children in certain child care settings, public schools or non-public schools, receive information outlining the benefits of immunization against meningococcal disease SUMMARY OF PROVISIONS: Section 1 of the bill provides that the Commissioner shall administer a program of meningococcal disease education and outreach to parents and guardians of children ages ten years to eighteen years of age who attend certain childcare programs, public schools or non-public schools. The Department of Health shall make educational materials regarding meningococcal disease and the benefits of meningitis immunizations available on the department's website. The Department of Education, and the New York City Department of Health and Mental Hygiene shall notify such childcare programs, public schools or non-public schools that information is available on DOH's website and that the information should be posted in plain view in anticipation of times of highest risk for contraction of meningitis as determined by the commissioner of health. Section 2 of the bill provides the effective date. JUSTIFICATION: This bill strengthens prevention measures to protect children's health and well-being by educating the children and their parents of the importance of receiving the meningococcal vaccination when entering the seventh grade. Meningococcal meningitis is a serious disease which can lead to death within only a few hours. Survivors may be left with a severe disability such as loss of limb, cognitive deficits, paralysis, deafness, or seizures. Meningococcal outbreaks can cause severe disruption of classes, campus life and alarm among students and faculty. The FDA has recently commented that "[m]eningococcal disease is a life-threatening illness caused by bacteria that infect the bloodstream (sepsis) and the lining that surrounds the brain and spinal cord (meningitis)... Even with appropriate antibiotics and intensive care, between 10 percent and 15 percent of people who develop meningococcal disease die from the infection. Another 10 percent to 20 percent suffer complications such as brain damage or loss of limb or hearing." This bill requires that educational materials regarding the meningococcal vaccine be made available and, if the adolescent subsequently receives the vaccine, the number of outbreaks should be substantially reduced. PRIOR LEGISLATIVE HISTORY: New Bill. FISCAL IMPLICATIONS: This bill will have no fiscal impact. EFFECTIVE DATE: This act shall take effect August 1, 2011.
S5069B-2011 Text
S T A T E O F N E W Y O R K
5069--B
2011-2012 Regular Sessions I N SENATE May 3, 2011
Introduced by Sen. HANNON -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- reported favorably from said committee and committed to the Committee on Finance -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said commit tee
AN ACT to amend the public health law, in relation to raising the level of immunity of children against meningococcal disease
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM BLY, DO ENACT AS FOLLOWS:
Section 1.
Section 2167 of the public health law, as added by chapter 165 of the laws of 2003, is amended to read as follows:
S 2167. Immunization against meningococcal meningitis. 1. As used in this section, unless the context requires otherwise:
a. The term "student" means [a] ANY person WHO IS IN SEVENTH GRADE OR A COMPARABLE AGE LEVEL SPECIAL EDUCATION PROGRAM WITH AN UNASSIGNED GRADE AT A SCHOOL, OR attending an institution and, in the case of a student attending college, "student" means a person who is registered to attend or who attends classes at an institution, who is enrolled for at least six semester hours or the equivalent per semester, or at least four semester hours per quarter. b. The term "institution" means an academy or college, as defined in section two of the education law, or a children's overnight camp as defined in section one thousand three hundred ninety-two of this chap ter, where the person attending such camp remains overnight for a period of not fewer than seven days. c. The term "immunization" means an adequate dose or doses of an immunizing agent against meningococcal meningitis which meets the stand ards approved by the United States public health service for such biological products and which is approved by the department under such EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD11275-07-1
S. 5069--B 2 conditions as may be specified by the public health AND HEALTH PLANNING council. D. THE TERM "SCHOOL" MEANS ANY PUBLIC, PRIVATE OR PAROCHIAL INTERME DIATE OR SECONDARY SCHOOL. 2. Each institution AND SCHOOL shall distribute, in a form provided or approved by the commissioner, written information about meningococcal meningitis and meningitis immunization to all students. The information provided by the institution OR SCHOOL shall include, but not be limited to, the following:
a. a description of the disease and means of transmission; b. the benefits, risks, and effectiveness of immunization; c. the availability and cost of immunization, including an indication of whether or not the institution OR SCHOOL offers meningococcal mening itis immunization services. 3. Each institution AND SCHOOL shall also distribute, in a form provided or approved by the commissioner [of health], a response form, to be completed by the student or, where the student is under the age of eighteen years, such student's parent or guardian, which shall include the following:
a. The student, or if under the age of eighteen years the parent or guardian of the student, certifies that the student has already received immunization against meningococcal meningitis within the ten years preceding the date of the response form; b. The student, or if under the age of eighteen years the parent or guardian of such student, has received and reviewed the information provided by the institution OR SCHOOL, understands the risks of meningo coccal meningitis and the benefits of immunization, and has decided that the student shall not obtain immunization against meningococcal meningi tis. The student, or if under the age of eighteen years the parent or guar dian of such student, shall indicate his or her decision in a box or space placed appropriately on the form and shall return the completed form to the institution OR SCHOOL. Nothing in this subdivision shall be construed to prohibit an institution OR SCHOOL from incorporating the form required by this subdivision into another health certificate or form required by the institution OR SCHOOL. 4. Each institution AND SCHOOL shall maintain [completed] A RECORD OF THE response [forms]. 5. No institution OR SCHOOL shall permit any student to attend the institution OR SCHOOL in excess of thirty days without complying with this section; provided, however, that such thirty day period may be extended to not more than sixty days if a student can show a good faith effort to comply with this section. 6. Nothing in this section shall be construed to prohibit institutions AND SCHOOLS from adopting or maintaining more stringent policies regard ing immunization against meningococcal meningitis.
S 2. This act shall take effect July 1, 2012; provided, that, effec tive immediately, any actions necessary to implement the provisions of this act on its effective date are authorized and directed to be completed on or before such date.

*By contributing or voting you agree to the Terms of Participation and Privacy Policy and verify you are over 13.
Discuss!
blog comments powered by Disqus